Castle Biosciences, Inc. CSTL NASDAQ

NASDAQ Global Market • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score

58/100

2/7 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Castle Biosciences, Inc. (CSTL), dont 13 achats et 37 ventes. Le total des achats d'initiés s'élève à RSU Award et le total des ventes d'initiés à $5.1M.

Les initiés notables ayant une activité récente comprennent Maetzold Derek J, Cotton Rodney, Juvenal Tobin W. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — CSTL

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-03-26	Maetzold Derek J	Pres. & Chief Exec. Officer	Vente Informative	278	$25.55	$7.1K	3,058
2026-03-26	Cotton Rodney	Director	Exercice d'Options (Vente)	5,329	-	-	5,330
2026-03-18	Maetzold Derek J	Pres. & Chief Exec. Officer	Vente Informative	650	$25.39	$16.5K	21,479
2026-03-17	Maetzold Derek J	Pres. & Chief Exec. Officer	Vente Informative	18,650	$25.93	$483.59K	22,129
2026-03-16	Maetzold Derek J	Pres. & Chief Exec. Officer	Vente Informative	126	$26.68	$3.36K	40,779
2026-03-13	Maetzold Derek J	Pres. & Chief Exec. Officer	Vente Informative	13,204	$25.45	$336K	58,354
2026-03-12	Maetzold Derek J	Pres. & Chief Exec. Officer	Vente Informative	23,179	$25.28	$585.94K	71,558
2026-03-12	Juvenal Tobin W	Chief Commercial Officer	Vente Informative	20,863	$25.24	$526.58K	86,825
2026-03-11	Maetzold Derek J	Pres. & Chief Exec. Officer	Vente Informative	279	$26.11	$7.28K	3,336
2026-03-05	Cole G Bradley	Director	Vente Informative	2,655	$28.51	$75.69K	19,309
2026-03-05	Stokes Frank	Chief Financial Officer	Vente Informative	6,001	$27.98	$167.91K	60,085
2026-03-04	Maetzold Derek J	Pres. & Chief Exec. Officer	Exercice d'Options (Vente)	31,110	-	-	62,218
2026-03-04	Stokes Frank	Chief Financial Officer	Exercice d'Options (Vente)	3,800	$3.38	$12.84K	14,912
2026-03-04	Juvenal Tobin W	Chief Commercial Officer	Exercice d'Options (Vente)	13,811	-	-	27,621
2026-03-04	Oelschlager Kristen M	Chief Operating Officer	Exercice d'Options (Vente)	13,811	-	-	27,621
2026-03-03	Maetzold Derek J	Pres. & Chief Exec. Officer	Retenue Fiscale RSU	19,043	$27.57	$525.02K	64,655
2026-03-03	Stokes Frank	Chief Financial Officer	Attribution de RSU	48,367	-	-	48,367
2026-03-03	Juvenal Tobin W	Chief Commercial Officer	Attribution de RSU	48,367	-	-	48,367
2026-03-03	Oelschlager Kristen M	Chief Operating Officer	Retenue Fiscale RSU	2,427	$27.57	$66.91K	20,068
2026-02-04	Maetzold Derek J	Pres. & Chief Exec. Officer	Vente Informative	171	$38.61	$6.6K	83,698
2026-02-03	Maetzold Derek J	Pres. & Chief Exec. Officer	Vente Informative	3,200	$39.91	$127.72K	84,515
2026-01-20	Maetzold Derek J	Pres. & Chief Exec. Officer	Vente Informative	4,017	$40.01	$160.73K	87,715
2026-01-12	Maetzold Derek J	Pres. & Chief Exec. Officer	Attribution de RSU	62,219	-	-	62,219
2026-01-12	Stokes Frank	Chief Financial Officer	Attribution de RSU	8,124	-	-	8,124
2026-01-12	Juvenal Tobin W	Chief Commercial Officer	Attribution de RSU	9,207	-	-	9,207
2026-01-12	Oelschlager Kristen M	Chief Operating Officer	Attribution de RSU	9,207	-	-	9,207
2026-01-06	Maetzold Derek J	Pres. & Chief Exec. Officer	Vente Informative	1,339	$40.10	$53.69K	29,513
2026-01-05	Maetzold Derek J	Pres. & Chief Exec. Officer	Vente Informative	2,678	$38.09	$102.01K	30,852
2025-12-22	Maetzold Derek J	Pres. & Chief Exec. Officer	Vente Informative	830	$40.35	$33.49K	33,530
2025-12-17	Maetzold Derek J	Pres. & Chief Exec. Officer	Vente Informative	509	$40.04	$20.38K	34,360
2025-12-17	Oelschlager Kristen M	Chief Operating Officer	Vente Informative	14,888	$39.31	$585.29K	12,323
2025-12-16	Maetzold Derek J	Pres. & Chief Exec. Officer	Vente Informative	12,821	$38.55	$494.3K	34,869
2025-12-15	Maetzold Derek J	Pres. & Chief Exec. Officer	Vente Informative	1,012	$39.30	$39.78K	47,690
2025-12-11	Stokes Frank	Chief Financial Officer	Vente Informative	4,496	$37.45	$168.38K	50,326
2025-12-11	Juvenal Tobin W	Chief Commercial Officer	Vente Informative	13,200	$37.48	$494.74K	86,825
2025-12-10	Maetzold Derek J	Pres. & Chief Exec. Officer	Exercice d'Options (Vente)	15,424	-	-	-
2025-12-10	Stokes Frank	Chief Financial Officer	Exercice d'Options (Vente)	6,170	-	-	-
2025-12-10	Juvenal Tobin W	Chief Commercial Officer	Exercice d'Options (Vente)	6,170	-	-	-
2025-12-10	Oelschlager Kristen M	Chief Operating Officer	Exercice d'Options (Vente)	6,170	-	-	-
2025-12-09	Maetzold Derek J	Pres. & Chief Exec. Officer	Exercice d'Options (Vente)	33,495	-	-	33,496
2025-12-09	Stokes Frank	Chief Financial Officer	Exercice d'Options (Vente)	14,616	-	-	14,617
2025-12-09	Juvenal Tobin W	Chief Commercial Officer	Exercice d'Options (Vente)	15,961	-	-	15,961
2025-12-09	Oelschlager Kristen M	Chief Operating Officer	Exercice d'Options (Vente)	15,961	-	-	15,961
2025-05-22	Bradbury Daniel	Director	Attribution de RSU	13,667	-	-	13,667
2025-05-22	Cole G Bradley	Director	Attribution de RSU	13,667	-	-	13,667
2025-05-22	Olson Tiffany	Director	Attribution de RSU	13,667	-	-	13,667
2025-05-22	Harrison Miles	Director	Attribution de RSU	13,667	-	-	13,667
2025-05-22	Goldberg Ellen	Director	Attribution de RSU	13,667	-	-	13,667
2025-05-22	Caple Kim	Director	Attribution de RSU	13,667	-	-	13,667
2025-05-22	Cotton Rodney	Director	Attribution de RSU	13,667	-	-	13,667

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration